Eugene Oltz, professor of pathology and immunology, and Marco Colonna, MD, the Robert Rock Belliveau, MD, Professor of Pathology, both at the School of Medicine, received a $3.4 million grant from the National Institutes of Health (NIH)’s National Institute of Allergy and Infectious Diseases to study how immune cells balance the need for a robust defense against infection against the risk of tissue damage. The study will focus on gene expression in cells implicated in inflammatory bowel disease.